DiscoverThe Redox Podcast
The Redox Podcast
Claim Ownership

The Redox Podcast

Author: Niko Skievaski

Subscribed: 7Played: 103


Explore some of the biggest problems in healthcare, and hear from industry leaders about how technology is being deployed to solve them. Hosted by Redox Co-founder and President, Niko Skievaski.
26 Episodes
Gil Addo is the co-founder and CEO of RubiconMD, the leading eConsults platform connecting primary care to specialists around the country.  I've known Gil for years and have always felt a kinship of sorts with him as I feel like we came from the same era of health tech startups, seeing him over and over again at similar early-stage digital health events around the country. Our conversation dives into his business quite a bit and explores factors in the changing healthcare landscape like value-based care, new primary care delivery models, and systemic racism in society and our industry. Key Moments: 01:54 - What does RubiconMD do? 08:12 - RubiconMD’s startup story 11:19 - How they solved the chicken or egg problem 14:24 - Emerging primary care models 17:09 - Pandemic-caused changes 27:07 - Are we still moving towards value-based care? 30:43 - Gil’s optimist view on systemic racism 34:40 - Shield implicit bias in specialty consults 36:40 - The future for RubiconMD Thanks again to Gil and the whole team at RubiconMD for the work they do. Find Gil on Twitter, LinkedIn, or RubiconMD’s website.
It’s an honor to have Bronwyn Spira, CEO of Force Therapeutics, on the show today. Force is a leading episode-based digital care platform and is also one of Redox’s first customers from back in 2015. We were able to catch up on what they’re seeing in the marketplace including how the pandemic has affected the world of episodic care that they primarily operate within. Key Moments: 02:00 - Force’s customers (NYU, Geisinger, Muve Health, Northwell, etc.) and what they do for them 09:25 - The importance of a clinical team 10:32 - Being in NYC for the pandemic and a Redox pizza party 14:02 - A VIRTUAL Escape Room?! (link here, thanks Rachel!) 15:29 - Standing up telehealth in one week 20:42 - Telehealth as a commoditized feature 22:03 - How do you digitize something so physical? 27:58 - Utilizing data for clinical research 34:43 - Collaborating with academics and AI for customized care plans 37:21 - A Redox commercial from Bronwyn ;) I think they’re a great example of how to build a multi-sided platform in healthcare. They were able to take advantage of regulatory tailwinds with the move to bundles to find early footing, then listen to their customers and patients to drive more value and engagement, then leveraged their data asset to contribute to research and improve their product experience by creating customized data-driven care plans. I’ve heard many many entrepreneurs pitch these sorts of stories but it’s far more rare—especially in healthcare—to see them fulfilled. Thanks again Bronwyn, for being on the show, for being a customer, and for the work you do to improve patient outcomes every day. -Niko Skievaski
Dr. Sarma Velamuri is an Internal Medicine doc, hospitalist, sepsis expert, and co-founder and CEO of Luminare, a company focused on the early detection of sepsis. On this episode, we dive into sepsis detection and prevention, as well as how these systems can work to help prevent the spread of other viral infections, like COVID-19.  Key Moments 01:39 How sepsis came to the forefront 03:33 Luminare’s tragic founding story 06:35 Alarm fatigue in EHRs and how to overcome it with workflow design 08:54 Luminare’s impact and value proposition 10:56 EHR integration with Redox* 13:07 Pivoting for pandemic response 15:39 Employers utilizing Luminare to screen employees for work 18:03 On safely reopening the economy *Full disclosure, Luminare is a Redox customer and it gets a little commercially in there for a minute. ;)  I find Luminare as a great example of a physician-founded startup doing it right, solving the problem through a focus on workflows and market demand. Big thanks to Sarma for taking the time to share his story. Enjoy!
On Tuesday, we had to layoff 44 Redoxers. That was about 25% of our team. On today's episode, we're going to go into the conditions that brought us to this place, how we went about making the decision to reduce the size of the team, and finally how we attach names to that decision.  Redox co-founders Luke Bonney (CEO) and Niko Skievaski (President) are joined by board member Raju Rishi. Raju is a general partner at VC firm RRE Ventures and led Redox's series B in January of 2017. Beyond sharing his perspective on the market and the layoffs he offers some relevant stories from his days as a founder. We thought sharing what we're going through might be helpful as I know a lot of people in our industry are attempting to figure out how to navigate the waters through recovery.  Additionally, Redox is working to place these 44 people at jobs within the industry. Contact to learn more.
Professor James Robinson is a highly-regarded expert on health care economics and policy. He is currently a Professor of Health Economics at the University of California, Berkeley and Director of the Berkeley Center for Health Technology. Dr. Robinson is also on the board of the Integrated Healthcare Association (IHA) and the National Institute for Healthcare Management (NIHCM). He has published three books and over 140 papers in peer-reviewed journals such as the New England Journal of Medicine and JAMA. He is also the former Editor-in-Chief of Health Affairs. Dr. Robinson’s book, “Purchasing Medical Innovation: The Right Technology for the Right Patient at the Right Price,” examined the roles of the FDA, health insurers, hospitals, and consumers in the assessment, purchasing and use of high-cost implantable devices.In this spirited conversation with Niko Skievaski, Dr. Robinson offers his insights into the current economic outlook for providers, hospitals, payers and patients - as well as a peek at what the post COVID-19 world might look like. You’ll enjoy the discussion.  Here are some of the highlights: 03:43 - “Anybody that talks about a V-shaped recovery is completely out of their mind.” 06:37 - The number of people with employee-based insurance is going to continue to drop. 11:12 - The impact of the pandemic on the business of healthcare. 13:59 - Lessons from the pandemic: Excess capacity and duplication are IN! Lean and global supply chains are OUT! 16:42 - “Most of what goes under the name of value-based care is just marketing!” 22:34 - The enormous impact of social determinants on health care. 29:30 - Looking at some of the positives ahead. Dr. Robinson is not shy about sharing his opinions, as well as his prescriptions for an improved economic outlook for the U.S. healthcare system. Our thanks to James Robinson for a thought-provoking edition of the Redox Podcast.
Redox CEO Luke Bonney was the featured guest on this week’s episode of Battery Venture’s “Powered by Battery” podcast series. The wide-ranging conversation covers everything from the company’s start as a digital-health incubator in Madison, Wisc. to its current position as an indispensable data exchange platform utilized by healthcare companies of all sizes. Luke also explains the creative ways that customers are using Redox to help in the fight against COVID-19. 02:42 - Redox’s roots; from Madison, WI start-up to remote digital healthcare innovator 06:01 - The need for scaling data integration for Cloud-based applications 08:31 - Helping customers deal with COVID-19 10:39 - How Redox powers telehealth applications  14:25 - Keeping Redoxers connected, informed and well during COVD-19 - personally and professionally 18:45 - Luke’s four priorities as Redox CEO 21:29 - The biggest unknown today is the economic impact caused by COVID-19 on American healthcare 25:50 - Policy creating tailwinds for interconnected healthcare 28:42 - Three things keeping Luke sane during COVID-19 - family, exercise and relationships  30:51 - The importance of surrounding yourself with the right people For more great investor insights, be sure to visit the “Powered by Battery” blog and podcast series.
Dr. Sylvia Romm is the chief innovation officer at Atlantic Health System, a 7-hospital organization based in northern New Jersey. A senior pediatrics resident at Harvard, Dr. Romm previously served as VP of Clinical Transformation with AmWell. She is also a highly-regarded author and speaker on topics related to healthcare, technology and health IT policy. Dr. Romm is driven by an entrepreneurial spirit and a passion for transforming healthcare delivery. She recently spent time talking with a former colleague and friend, Redox’s Chief Customer Officer Elif Eracar.  Here are some of the highlights from this fun and insightful interview: 02:15 - Dr. Romm’s journey from pediatric hospitalist to telehealth innovator 04:25 - From starting MilkOnTap to AmWell 07:01 - Advantages and challenges of virtual health providers 10:10 - Telehealth’s ability to mitigate physician burnout 13:50 - Current state of value-based care 16:38 - The importance of making healthcare easily understood 19:48 - How COVID-19 has impacted the trajectory of telehealth 23:14 - Telehealth as a career option Our thanks to Dr. Sylvia Romm of Atlantic Health System for sharing her insights with us. Telehealth is destined to become an integral part of the healthcare experience in the years ahead - and leaders like Dr. Romm are leading the way. Thank you for listening to the Redox Podcast.
Welcome to Part 2 of our discussion of Platforms in Healthcare. I was pleased to be joined by: Anurati Mathur, CEO of Sempre Health Carlo Perez, CEO of Swift Medical Dr. Mitesh Rao, CEO of OMNY Health  Niko Skieavski, President of Redox Seth Joseph, managing director of Summit Health, served as our moderator. This portion starts with ideas on how to tackle the chicken or egg problem, the concept of viral growth, and how to finance platform operations. Finally, we tackle the problem of what makes healthcare so different for those launching multi-platform businesses. 01:36 – Carlo Perez explains how Swift tackled the issue of building a multi-sided platform 04:55 – Niko on starting by adding real value to one side 07:39 – Sempre’s rationale for focusing on the payer side at the outset 11:55 – Leveraging early adopters to gain experience and credibility 16:20 - Financing multi-sided platforms 21:46 – Lessons learned by these entrepreneurs. Our thanks to Seth, Anurati, Carlo, and Mitesh for sharing their experiences and opinions. These are some of the creative and passionate people that are working hard every day to change healthcare for the better. We look forward to watching their companies grow in the months and years ahead. Thank you for listening to the Redox Podcast.
Redox is an example of a platform business model in healthcare. We connect healthcare organizations and software vendors with reusable technology, thus creating a scalable network of data exchange. In addition to Redox, there are a number of other really innovative companies using platform business models to solve major challenges in healthcare. The opportunities to make a positive difference in how healthcare is delivered are exciting, but the challenges are numerous. So a number of us decided to get together to share experiences and ideas. Our guests for this two-part program include: Anurati Mathur, CEO of Sempre Health Carlo Perez, CEO of Swift Medical Dr. Mitesh Rao, CEO of OMNY Health Niko Skievaski, President of Redox And I was pleased to have Seth Joseph, managing director of Summit Health, join us as moderator.  Previously, Seth was head of corporate strategy for Surescripts, one of the few nationally scaled multi-sided platform businesses in healthcare. Surescripts is now processing 19 billion clinical transactions a year.  In the first episode, we examine multi-sided platforms, networks, and their business models. Some of the highlights from Part 1 include: 03:00 – Niko and Seth provide background on platform businesses 06:50 – The Surescripts experience 13:35 – How OMNY creates value for users 16:08 – Sempre Health’s approach 18:58 – Which side of the market should be charged? 23:49 – Anurati discusses incentive alignment 28:15 – Swift’s rigorous credentialing process
Dr. Roxie Mooney is CEO & Healthcare Innovation Strategist of Legacy DNA, a company that helps health innovators move from idea to full market adoption. Legacy DNA is known for its COIQ System - which is a mash-up of the acronym COI, “commercialization of innovation,”  with IQ. COIQ represents the knowledge and insights that health innovators need to maximize market success. Over the past 20 years, Dr. Roxie has helped to generate marketplace success for a wide range of health and lifestyle companies. She generously shared her insights with Niko Skievaski in this conversation.  Here are some of the highlights: 02:35 – Being creative and helpful during COVID-19 07:25 – Building an early adoption strategy 15:35 – How to avoid “pilot purgatory” 20:18 – The role health systems play in helping innovators come to market – for better or worse 25:43 – Changes for technology developers as they cope with changing sales cycles 31:40 – What can start-ups do to stay viable during the current economic disruption? Our thanks to Dr. Roxie Mooney for sharing her expertise with us on The Redox Podcast.
With COVID-19 dominating world events, Dr. Geeta Nayyar generously shared her time, insights and advice with Niko Skievaski. Doctor Nayyar is the chief medical officer for Greenway Health and a nationally recognized leader in health information technology. Prior to joining Greenway, she held positions as chief healthcare and innovation officer at Femwell Group Health and CMIO at AT&T. In addition to her business responsibilities, Dr. Nayyar is a practicing rheumatologist and maintains faculty affiliation with the University of Miami, where she teaches at the medical school. Doctor Nayyar is the author of the mobile health chapter in the HIMSS Medical Informatics textbook and is a six-time HIMSS Digital Influencer.  The conversation is fascinating from start to finish – here are a few chapter sections. 02:12 – COVID-19 has changed things for everyone. 12:18 – Where is technology’s place in this pandemic? 16:46 – When will the curve be flattened? 18:44 – How long might this last? 25:19 – We didn’t do a good job of translating the problem. 26:20 – Pay attention to Dr. Fauci and the CDC guidelines. 31:36 – Social distancing activities It is astonishing to witness the skill and selfless commitment of healthcare workers around the world as they fight every day to provide the best possible care for their patients during these gut-wrenching days. Our thanks to Dr. Geeta Nayyar for sharing her expertise with us on The Redox Podcast.
We're in the midst of a worldwide pandemic that will strain our healthcare delivery system beyond anything we've seen before. Those of us who work in healthcare technology have reprioritized to attempt to bring something novel--something of use--to the new challenges faced by health systems. This is a special episode of the podcast including guests from 10 digital health vendors who have created a COVID-19 specific solution. From the time a patient thinks they have symptoms, to getting on a waiting list, to triaging in an overcrowded and socially-distant emergency department, to care within the hospital and beyond, digital health solutions have stepped up to fight this pandemic. 1:15 - Social distancing and the excess demand problem 3:26 - Hypothesis: technology can be used to increase caregiver efficiency and effectiveness 6:02 - Vital and screening tool 9:00 - Epion's remote check-in and triage solution 11:13 - Gauss and Operation Apollo for contactless triage 14:35 - ER Express's virtual waiting room 16:14 - Bravado and the forgotten patient population 18:09 - Redivus reducing errors in cardiac arrest 22:00 - EmOpti's streamlined telehealth triage 26:19 - CareLoop in reducing PPE and better communication 32:22 - Logical C19 Tracker for remote patient monitoring 35:02 - MedBridge's COVID-19 patient and provider education tool kit We adopted these tracks from our 3/25 virtual conference: Innovate COVID. Check out our COVID-19 resource center for more solutions and videos from the conference.
Fred Holliday was diagnosed with metastatic kidney cancer in 2010. At one point, his wife Regina asked to see Fred’s medical records. Fred and Regina were astonished by what they experienced – how difficult, and in some cases impossible, it was to access crucial personal health data. Fred passed away in mid-June of that year, at only 39 years old. In one of his final messages, he passed a handwritten note to his wife that read, “Go After Them Regina, Love Fred.”As an artist, Regina was able to express her grief and frustration through her paintings. She was invited to create a mural on the back of a gas station on Connecticut Avenue in Washington, DC. She titled the piece “73 Cents,” because that was the quoted price per page for Fred’s paper medical record. Less than a month after beginning the mural, Regina was talking to members of the US Senate and to reporters around the world. The painting, which can still be seen today in the nation’s capital, helped make patient access to data become a core measure in the Meaningful Use legislation in 2010. From this tragic experience was born “The Walking Gallery.” After the mural became widely known, Regina began painting patient and family stories on the back of jackets and blazers. These stories often come from a place of deep pain; such as the death of a loved one or a chronic condition that they a patient battles every day.   There are now 466 members wearing jackets painted by 52 artists. Regina herself has painted over 400 jackets! At HIMSS20 next week - and other healthcare events - you’ll see members of the Walking Gallery strolling around the conference. Niko Skievaski spoke with Regina Holliday about the Walking Gallery and her ongoing quest to ensure patients and families can access data when they need it. 02:11 – Regina’s shocking experience trying to access her husband’s patient data 04:38 – The “horrific” conditions fueled her advocacy 06:22 – An AMA meeting attendee asks for a painted jacket – the start of the Walking Gallery 10:40 – Having access to data is empowering for the patient 18:51 – The “ripple” impact of the Walking Gallery 21:07 – How can people get a painted jacket? 23:32 – If you see someone wearing a Walking Gallery jacket, feel free to ask the person their story  Regina Holliday travels the globe spreading her message of patient empowerment and inclusion in healthcare decision making. Our thanks to Regina for sharing her story on The Redox Podcast.
Pink Socks Life is a nonprofit organization focused on promoting human connection around the world by socially supporting other public charities. If you have been to a health tech conference in the last five years, you’ve likely seen people wearing pinksocks with mustaches on them. Well, the movement began – somewhat accidentally – at the HIMSS conference in 2015. Today, this community of over 100,000 happy smiley people are united in working to change the world from the ground up – with heart speak, hugs, and gifting. As HIMSS20 draws near, Niko Skievaski chatted with the founders of pinksocks – Nick Adkins and Andrew Richards.  01:30 – The accidental start of pinksocks   05:43 – Creating a shared cultural narrative 11:12 – How the “gifting” ethos at Burning Man struck a nerve with Nick  15:40 – Expanding from healthcare into education  20:30 – Additional charities that pinksocks works with 27:15 – How to get involved with the pinksocks movement 32:15 – Description of the pinksocks blog, which chronicles how pinksocks has impacted lives around the world The pinksocks movement has grown from healthcare into all kinds of industries around the world. And, as stated on the pinksocks website – “The pinksocks are our reminder that shared connection is what it’s all about. Have fun! Smile! Give hugs! Life, it’s happening right now! Don’t miss it!”Our thanks to Nick Adkins and Andrew Richards for joining us on The Redox Podcast – and, more importantly, for spreading kindness through Pinksocks Life.
#11 HIMSS20 Preview

#11 HIMSS20 Preview


The HIMSS20 Global Health Conference takes place next week in Orlando. Participants from all corners of the industry – from vendors, clinicians and health system executives to policymakers and patient advocates – will get together to learn, share ideas and socialize. The enormity of the conference – nearly 45,000 professionals from more than 90 countries – can be overwhelming. Niko Skievaski had the chance to catch up with three long-time HIMSS participants who were happy to share their perspective on what to expect and how best to navigate HIMSS. This lively and informative conversation includes: Lygeia Ricciardi, chief transformation officer at Carium and former ONC official ( John Lynn, founder of ( Colin Hung, editor of ( Here are some of the highlights from their conversation: 02:28 – Most memorable HIMSS experiences   07:32 – Top three things experts are looking for at HIMSS20 13:06 – Thoughts on the pending ONC rules 20:20 – The role of Big Tech in healthcare 26:25 – Advice for navigating HIMSS20 While concerns about the coronavirus may impact the travel plans of some, HIMSS20 is slated to take place as scheduled and we expect it to be another massive event – one that spreads knowledge, creates relationships, and sparks innovation. Our thanks to Carium’s Lygeia Ricciardi and Colin Hung and John Lynn of Healthcare IT Today for joining us on The Redox Podcast.
At Redox, we might have a bit of a startup crush on Roundtrip. But that’s easy when you work with such impactful companies. Every day, 10,000 patients miss or delay necessary health care due to a lack of proper transportation. The cost to the United States healthcare system last year because of missed medical appointments and unfulfilled prescriptions was a staggering $150 billion. But this problem goes way beyond dollars and cents. The greater concern is the health of millions of patients who aren’t getting the care and medication they need – simply because they don’t have a ride. In 2016, Ankit Mathur, Angela Damiano, and Mark Switaj banded together to design a ride ordering solution that improves access to care. The company they founded is Roundtrip. Ankit, Roundtrip’s chief technology officer, recently sat down with me to share their story. Here are some of the highlights from their conversation. 01:55 – How Roundtrip got started   04:41 – Getting a multi-sided network off the ground 09:25 – Roundtrip’s early milestones 19:09 – Attracting providers, patients and transportation services to participate 27:45 – The importance of value-based care 35:15 – How the network effect propels Roundtrip’s go-to-market strategy 38:27 – What’s ahead for Roundtrip? Roundtrip is making a significant difference in the quality of care for patients. MedCity just reported that they’re saving Contra Costa 25% over taxi and bus vouchers, in preliminary results. We look forward to watching the company grow in the years ahead. Our thanks to Ankit Mathur for joining us on The Redox Podcast.
Aaron Patzer is founder and CEO of Vital, AI-powered software for hospital emergency rooms and patients.  As an entrepreneur, Aaron has had success at a number of companies, most notably the ground-breaking – which he founded in 2006 and eventually sold to Intuit. The success of shook up the financial services industry and paved the way for other innovators, including Plaid, the platform that  enables applications to connect with users’ bank accounts (Visa acquired Plaid for $5.3 billion in 2020). Last year, Aaron launched Vital to bring a similar consumer-focused mindset to emergency rooms and hospitals. However, as you’ll hear in this fascinating conversation between Aaron and Niko Skievaski, creating “a for the healthcare industry” is not an easy task. There are significant differences and obstacles to be addressed. But these two innovators are confident that transformation is coming. Listen on…Here are some of the leading topics. 02:31 – How came to be 10:40 – Why isn’t there a yet for healthcare? 17:02 – Applying the lessons learned at to healthcare 23:10 – What is “adversarial interoperability?” 26:43 – A bit about Vital 37:08 – Enabling providers with the right information at the right time so they can provide the best care 46:55 – Powering applications that make a difference Aaron Patzer was one of the major figures responsible for disrupting the enormous personal finance market. We’re anxious to see the results of his foray now into digital healthcare. Our thanks to Aaron Patzer for joining us on The Redox Podcast.
With HIMSS 2020 coming up soon, Niko Skievaski spent some time chatting with Attorney Matthew Fisher, a partner at the law firm of Mirick O’Connell in Westborough, Massachusetts. Matt is the chair of the firm’s Health Law Group and one of the HIMSS top 10 Digital Influencers. Additionally, Matt is the host of the well-known Healthcare de Jure podcast. Niko and Matt covered a lot of ground in this conversation focused on data privacy rights. Here are some of the leading topics. 02:37 – Today’s biggest regulatory and compliance challenges 13:18 – Data blocking and a patient’s right to access 22:28 – Epic’s concerns about the new ONC rules 32:25 – Data sharing with business “associates”  41:55 – De-identifying data – can it ever be done 100% 50:38 – Building a culture of compliance in the decade ahead Our thanks to Attorney Matthew Fisher for sharing his insights and expertise on healthcare data privacy rights.
Aneesh Chopra is one of the foremost names in healthcare IT today. He was appointed by President Barack Obama to serve as the United States’ first Chief Technology Officer. After his three years as CTO, President Obama hailed his service, saying Chopra’s “legacy of leadership and innovation will benefit Americans for years to come.” In the years since he served as the nation’s CTO, Chopra has worked tirelessly to promote a better and more efficient healthcare system. Aneesh was one of the four industry leaders that convened the CARIN Alliance in 2016, a bipartisan, multi-sector collaborative working to advance the consumer-directed exchange of health information. He was also part of the founding group that started the Argonaut Project, an effort designed to accelerate the development and adoption of HL7’s Fast Healthcare Interoperability Resources (FHIR®) standard. Chopra authored a book, “Innovative State: How New Technologies can Transform Government.” Currently, Aneesh is president of CareJourney, a healthcare analytics company based in Arlington, Virginia. Aneesh Chopra and Niko Skievaski covered many important issues in this engaging conversation. Some of the topic highlights can be found at: 02:25 – Aneesh’s service as U.S. CTO 15:12 – The role of government policy in encouraging innovation in healthcare 25:12 – Evolving infrastructure and incentives to promote interoperability  33:54 – Explaining the new rules from CMS 45:11 – Creating the apps that will facilitate consumer and industry adoption of new programs    54:05 – Resources for driving interoperability Interoperability and open APIs are clearly things that Aneesh Chopra believes will improve patient care and reduce the cost of healthcare. This new interop paradigm will be accomplished sooner if private and public forces work collaboratively in the interest of a better system for all Americans.Our thanks to Aneesh Chopra for joining us on The Redox Podcast.
As patients, the traditional pharmacy business seems to be a mess. It appears to be a jumble of information exchange, insurance contracts, middlemen, generics, phone calls, faxes, cross-subsidies, and misaligned incentives. The process can be frustrating, time-consuming, and expensive. As if that’s not bad enough, it can often result in patients not adhering to their medication routine. Fortunately, there are some creative entrepreneurs working on ways to improve the system. Leading the charge is Alto Pharmacy. While in the Bay Area for the recent J.P. Morgan Healthcare Conference, Niko Skievaski sat down with Alto’s CEO Mattieu Gamache-Asselin for a lively discussion about the pharmacy of the future. We invite you to enjoy the entire conversation. A few highlights can be found at these times:  02:08 – Matt’s back-end roots working with Parse 06:10 – Buying a pharmacy to really understand both the business and patient needs. 11:10 – Creating the ideal patient experience 20:21 – Alto’s process and how patients realize value 26:43 – New challenges to be solved in the months and years ahead 31:39 – With all the stakeholders in healthcare, is it possible to create value for everyone? 37:11 – Create change “one step at a time” While Alto is relatively unknown to consumers nationwide today, that’s only because they’ve prudently chosen a disciplined approach to perfecting their new model for pharmacy service. Focusing on select markets allows Alto to prove the economics of their model, discover the most efficient way to operate, and, most importantly, ensure great customer experiences. This strategy will serve them well in the long term and it’s only a matter of time before Alto is a well-known national brand name. Thank you for listening to this episode of The Redox Podcast.
Download from Google Play
Download from App Store